STOCK TITAN

Cencora, Inc. - COR STOCK NEWS

Welcome to our dedicated page for Cencora news (Ticker: COR), a resource for investors and traders seeking the latest updates and insights on Cencora stock.

Cencora, Inc. (NYSE: COR) is a premier global pharmaceutical solutions provider committed to enhancing healthcare delivery and improving lives worldwide.

As one of the top three pharmaceutical wholesalers in the United States, Cencora specializes in sourcing and distributing branded, generic, and specialty pharmaceutical products to a diverse range of clients, including retail chains, independent pharmacies, mail-order services, hospital networks, and healthcare providers. In collaboration with McKesson and Cardinal Health, Cencora dominates over 90% of the U.S. pharmaceutical wholesale market.

Beyond its robust domestic operations, Cencora has significantly expanded its international footprint. Notably, the acquisition of Alliance Healthcare in 2021 bolstered its presence in Europe, making it one of the leading drug wholesalers in the region.

Additionally, Cencora offers comprehensive commercialization services for pharmaceutical and medical device manufacturers. Its global specialty drug logistics division, World Courier, is renowned for its precision and reliability. The company also extends its expertise to animal health product distribution through MWI Animal Health.

Cencora's strategic partnerships and innovative solutions drive operational efficiency, cost control, and growth opportunities across the healthcare supply chain.

  • Its pharmacy solutions enhance operational efficiency, cost control, growth opportunities, and patient safety.
  • Provider solutions focus on improving operational efficiency, financial performance, and quality of care.
  • Manufacturer solutions are designed to maximize success at every stage of the product lifecycle.


Recent achievements include a distribution agreement with Sapphiros, enhancing access to COVID-19 Antigen Rapid Tests and future diagnostic technologies in the U.S. market. This partnership is poised to bring innovative diagnostic solutions directly to patients, exemplifying Cencora's commitment to improving accessibility and convenience in healthcare.

Cencora’s mission is driven by a strong sense of purpose: 'We are united in our responsibility to create healthier futures.' Ranked #11 on the Fortune 500 and #24 on the Global Fortune 500, with annual revenues exceeding $250 billion, Cencora’s over 46,000 team members worldwide are dedicated to delivering positive health outcomes through their expertise and collaborative efforts.

Rhea-AI Summary

American Tower Corporation (NYSE: AMT) announced the expiration of its tender offer for CoreSite Realty Corporation (NYSE: COR) shares, completing the acquisition via a merger with its subsidiary, Appleseed Merger Sub LLC. The tender offer, which ended on December 27, 2021, resulted in 31,443,126 shares tendered, accounting for approximately 71.15% of CoreSite's outstanding shares. CoreSite will merge into American Tower on December 28, 2021, with its shares ceasing to trade on the NYSE. Each CoreSite share will convert to $170.00 in cash, matching the tender offer price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
none
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) has announced that its VA3 data center is now powered by 100% renewable energy through Dominion Energy's 100% Renewable Energy Program. This initiative supports local renewable energy development in the Northern Virginia market. CoreSite aims to assist its customers in achieving their sustainability goals by offering a diverse energy portfolio, including solar, hydroelectric, and biomass sources. The VA3 facility, part of a larger data center campus, provides significant capacity and connectivity to major cloud providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

American Tower Corporation (NYSE: AMT) has launched a tender offer for all outstanding shares of CoreSite Realty Corporation (NYSE: COR), proposing $170.00 per share in cash. This move is part of a merger agreement announced on November 15, 2021. The tender offer will expire on December 27, 2021, unless extended, and is contingent upon acquiring a majority of CoreSite's shares. The CoreSite board recommends that shareholders accept the offer. Details regarding the tender offer and related documents are available from the SEC and other sources.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
none
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) has been named a 2021 Northern Virginia Technology Council (NVTC) Tech 100 Company, recognizing its innovative contributions to the tech industry. Additionally, CoreSite’s SVP of General Management, Juan Font, received the 2021 NVTC Tech 100 Executive accolade. The Tech 100 list highlights 64 tech companies and 33 executives who have demonstrated leadership and innovation in Northern Virginia’s tech sector. CoreSite supports over 350 enterprise and government customers with secure multi-cloud hybrid IT solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
none
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) announced a cash dividend of $1.27 per share for Q4 2021, maintaining the same amount as the previous quarter. This dividend will be distributed on December 13, 2021, to shareholders who are on record by December 2, 2021. The company is known for its high-performance data center campuses, providing cloud access and interconnection solutions across major U.S. metropolitan areas.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
dividends
-
News
Rhea-AI Summary

American Tower announced its acquisition of CoreSite Realty for $170.00 per share, totaling approximately $10.1 billion including debt. The merger aims to enhance American Tower’s offerings in the evolving 5G landscape, accelerating growth in mobile edge computing. CoreSite has shown impressive financials with $655 million in annual revenue and strong EBITDA margins, and has experienced double-digit growth over five years. The deal is expected to close by the end of 2021, proving accretive to American Tower’s AFFO initially and more so over time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
News
Rhea-AI Summary

American Tower Corporation (AMT) announced it will acquire CoreSite Realty Corporation (COR) for $170 per share in cash, totaling approximately $10.1 billion, including debt repayment. This strategic move aims to create a comprehensive communications real estate platform, enhancing the companies' positions in the growing 5G market. CoreSite’s strong performance, with annual revenue of $655 million and an EBITDA of $343 million, coupled with American Tower's global reach, is expected to accelerate growth and broaden service offerings. The transaction is projected to close by the end of 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) is co-presenting the Infinity Festival 2021 in Hollywood, CA from November 2-4. The festival merges storytelling and technology, showcasing innovations in media and entertainment, featuring both in-person and virtual events. CoreSite aims to demonstrate how its interconnection solutions support media clients in monetizing their business. 5G technology will be highlighted, with discussions on its pivotal role in immersive media. Key speakers include CoreSite's Brian Eichman, presenting on 5G's Starring Role in Immersive Media on November 3.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
conferences
-
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) reported strong Q3 2021 financial results, showcasing a 6.4% year-over-year revenue growth to $163.9 million. Net income remained stable at $0.50 per diluted share. Notably, adjusted EBITDA rose 5.2% to $85.7 million, while Funds From Operations (FFO) increased 4.5% to $1.39 per share. The company renewed 296 leases, reflecting an increase in cash and GAAP rent. Updated guidance for capital expenditures is now $140 million to $150 million, a reduction from the earlier range. Overall, CoreSite's strategic leasing and development activities remain robust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
Rhea-AI Summary

CoreSite Realty Corporation (NYSE:COR) will host its third quarter 2021 earnings conference call on October 28, 2021, at 12:00 p.m. ET. Financial results will be released before market open on the same day. Investors can join the call by dialing 1-877-407-3982 (domestic) or 1-201-493-6780 (international). A replay will be available until November 4, 2021. The call will also be broadcast as a webcast on the company's website, providing insights into its performance and strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags

FAQ

What is the current stock price of Cencora (COR)?

The current stock price of Cencora (COR) is $243.2 as of November 20, 2024.

What is the market cap of Cencora (COR)?

The market cap of Cencora (COR) is approximately 47.6B.

What does Cencora, Inc. do?

Cencora, Inc. is a leading global pharmaceutical solutions provider, specializing in the sourcing and distribution of branded, generic, and specialty pharmaceuticals.

Who are Cencora's main clients?

Cencora serves retail chains, independent pharmacies, mail-order services, hospital networks, and healthcare providers.

What are some recent achievements of Cencora?

Cencora recently entered into a distribution agreement with Sapphiros to enhance access to COVID-19 Antigen Rapid Tests and future diagnostic technologies in the U.S.

How significant is Cencora in the U.S. pharmaceutical wholesale market?

Cencora, along with McKesson and Cardinal Health, constitutes over 90% of the U.S. pharmaceutical wholesale industry.

What international presence does Cencora have?

Cencora expanded its international presence by acquiring Alliance Healthcare in 2021, becoming a leading drug wholesaler in Europe.

What other services does Cencora provide?

Cencora offers commercialization services for pharmaceutical and medical device manufacturers, global specialty drug logistics, and animal health product distribution.

What is Cencora’s mission?

Cencora's mission is 'We are united in our responsibility to create healthier futures.'

How is Cencora ranked on the Fortune 500?

Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500.

What is the scale of Cencora's operations?

Cencora has over 46,000 employees worldwide and generates more than $250 billion in annual revenue.

What are some key solutions provided by Cencora?

Cencora provides pharmacy solutions for operational efficiency and patient safety, provider solutions for quality care, and manufacturer solutions for product lifecycle success.

Cencora, Inc.

NYSE:COR

COR Rankings

COR Stock Data

47.61B
175.34M
10.47%
90.81%
5.08%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
CONSHOHOCKEN